pegylated liposomal doxorubicin - Generic mfg.
ATRC-101 - Atreca
Keytruda (pembrolizumab) - Merck (MSD)
https://www.globenewswire.com/news-release/2021/11/02/2325381/0/en/Atreca-Reports-Third-Quarter-2021-Financial-Results-and-Recent-Corporate-Developments.html
 
Nov 2, 2021
 
Prev Next